Pasithea Therapeutics Drug Shows Tumor Reduction In Pancreatic Cancer, Strong Early Trial Results

benzinga.com/general/biotech/25/05/45221957/pasithea-therapeutics-drug-shows-tumor-reduction-in-pancreatic-cancer-strong-early-trial-results

Pasithea Therapeutics Corp. (NASDAQ:KTTA) is trading higher in the premarket session on Tuesday with a session volume of 22.14 million compared to the average volume of 2.81 million as per data from Benzinga Pro.
The clinical-stage biotechnology company released interim pharmacodynamic…

This story appeared on benzinga.com, 2025-05-06 13:29:09.
The Entire Business World on a Single Page. Free to Use →